Skip to main content
. 2016 Sep 19;7(43):69267–69275. doi: 10.18632/oncotarget.12121

Table 4. Pathological and molecular detains in 8 patients with recurrent HCC.

Case No. Stage (primary) ES grade (primary/recurrent) Vascular invasion (primary/recurrent) Tumor multiplicity (primary/recurrent) TERT mutation (primary/recurrent) CTNNB1 mutation (primary/recurrent)
1 4 3/4 Micorvascular/Micorvascular invasion No/No Wild/Wild Mutant/Mutant
2 2 3/2 No / No invasion Yes/No Wild/ND Wild/Wild
3 1 3/2 No / No invasion Yes/Yes Wild/Wild Wild/Wild
4 3a 2/3 Macrovascular / No invasion Yes/Yes Wild/Wild Wild/ND
5 2 3/2 Microvascular / No invasion Yes/No Wild/Mutant Wild/Wild
6 2 2/2 No / No invasion No/No Wild/Mutant Wild/Wild
7 2 3/3 No / No invasion Yes/Yes Mutant/Mutant Wild/Wild
8 1 3/3 No / No invasion No/No Wild/Wild Wild/Wild